By Dr Wendy Winnall - PCFA Research TeamA recent prostate cancer study from Canada has received a lot of publicity. This study measured the risk of ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

Repare Therapeutics shares jumped in premarket trading after the company agreed to sell its polymerase theta ATPase inhibitor to Gilead Sciences for up to $30 million. Shares were 18% higher at $2.57 ...

Gilead agreed to acquire Repare's RP-3467 cancer drug for up to $30 million, boosting Repare's cash and expected shareholder payout.

There is a shadow disease that often lurks unnoticed, growing quietly within a man’s body which is hidden behind the mundane routine of daily life, masked by ag ...

A published case series reports unexpected cancer remissions linked with fenbendazole use, prompting renewed discussion on ...

Pancreatic cancer accounts for about 8% of all cancer deaths. Ben Sasse says he expects to be one of them. Here's what to ...

Former Republican Sen. Ben Sasse, who became known for breaking party ranks to criticize President Donald Trump and voted to ...

Mr. Sasse, a former senator from Nebraska, announced that he had received a diagnosis last week for Stage 4 pancreatic cancer ...

Common symptoms that palliative care teams see in patients with metastatic breast cancer include pain, menopausal symptoms, ...

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec. 23, ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...